91九色视频

header-logo
GettyImages-609179959-hero
headshot

Jenna Sarvaideo, DO

Associate Professor, Fellowship Director

view physician profile

Locations

  • Froedtert Hospital

Specialties

  • Endocrinology

Languages

  • English

New & Established Patients Call

General Interests

Andropause, Health Services for Transgender Persons, Hypogonadism, Klinefelter Syndrome, Menopause, Polycystic Ovary Syndrome, Turner Syndrome

Education

  • DO - Doctor of Osteopathic Medicine

Biography

Jenna Sarvaideo, DO, is an Associate Professor of Medicine in the Division of Endocrinology at the 91九色视频 and the Milwaukee VA. She specializes in female and male hormone conditions, including menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Dr. Sarvaideo is actively involved in clinical research, currently leading two projects on male hypogonadism at the VA.

She completed her endocrinology fellowship at the 91九色视频 in 2017 and joined the Division of Endocrinology and Molecular Medicine as an Assistant Professor the same year. She currently serves as the Director for the Endocrinology Fellowship Program and is a participant in the Clinical Research Scholars Program through the Clinical and Translational Science Institute of Southeastern Wisconsin.

Dr. Sarvaideo is the principal investigator for two clinical trials involving oral and sublingual estradiol in transgender women and contributes to a quality improvement initiative at the 91九色视频 Inclusion Health Clinic. She is passionate about mentoring fellows, residents, and medical students, and was recognized with an Endocrine Society Summer Research Fellowship Award in 2019 and a 91九色视频 Research Affairs Committee grant in 2020.

She is actively engaged in several national and international medical societies, including the Endocrine Society, World Professional Association for Transgender Health (WPATH), North American Menopause Society, and the Androgen Society. She also serves on the Endocrine Society’s Transgender Research and Medicine Special Interest Group (SIG) Steering Committee.

Education

  • BA, Art History and Chemistry, New York University, New York, NY, 2008
  • DO, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, 2012

Leadership Positions

  • Director, Endocrinology Fellowship Program
  • Lead Reviewer, WPATH 26th Scientific Review Committee, 07/17/2020 – 08/03/2020

Research Areas of Interest

  • Hypogonadism

Research Experience

  • Transgender Persons

Clinical Expertise

  • Andropause
  • Health Services for Transgender Persons
  • Hypogonadism
  • Kallmann Syndrome
  • Klinefelter Syndrome
  • Menopause
  • Polycystic Ovary Syndrome
  • Turner Syndrome

Research Interests

Clinical Trials involving transgender women. Transgender medicine, male hypogonadism, menopause, PCOS, premature ovarian insufficiency, Turner Syndrome, Klinefelter Syndrome

09/2018 - Present, Sublingual Estradiol Versus Oral Estradiol in Transgender Women
Primary Aim. To establish the pharmacokinetics of sublingual estradiol versus oral estradiol in transgender women.
ClinicalTrials.gov Identifier: NCT04036500

Current, Coagulation Activation and Fibrinolysis with Sublingual versus Oral Estradiol in Transgender Women
Primary Aim 1: To measure coagulation system activation and fibrinolysis following sublingual versus oral estradiol administration in transgender women.
ClinicalTrials.gov Identifier pending

Current, The Utility of Monitoring Potassium in Transgender Women on Spironolactone.

Publications

  • (Sarvaideo JL, Colón-Franco JM, Kumar R, Shaker JL.) JBMR Plus. 2025 Sep;9(9):ziaf102 PMID: 40765620 PMCID: PMC12319318 SCOPUS ID: 2-s2.0-105012510883 08/06/2025

  • (Nerenz RD, Javorsky BR, Sarvaideo J, Straseski JA, Earll E.) Clin Endocrinol (Oxf). 2025 May;102(5):557-558 PMID: 39777755 SCOPUS ID: 2-s2.0-85214406364 01/09/2025

  • (Meghan McCallum, Barbara Bekiesz, Jenna Sarvaideo.) MDLinx. 03/18/2025

  • (Rothman MS, Hamnvik OR, Davidge-Pitts C, Safer JD, Ariel D, Tangpricha V, Abramowitz J, Soe K, Sarvaideo J, Kelley C, Irwig MS, Iwamoto SJ.) Transgend Health. 2024 Dec;9(6):463-465 PMID: 39735380 PMCID: PMC11669617 12/30/2024

  • (Earll E, Javorsky BR, Sarvaideo J, Straseski JA, Nerenz RD.) J Endocr Soc. 2024 Apr 06;8(6):bvae069 PMID: 38698869 PMCID: PMC11065352 05/03/2024

  • (Afsari, Seema; Lynd, Francesca; Sarvaideo, Jenna; Lippman, Alyson.) MKE Lifestyle. 08/01/2024

  • (SenthilKumar G, Katunaric B, Bordas-Murphy H, Sarvaideo J, Freed JK.) Endocrinology. 2023 Apr 17;164(6) PMID: 37207450 PMCID: PMC10230790 SCOPUS ID: 2-s2.0-85163898622 05/20/2023

  • (Wolf Pulsiano SL, Sarvaideo JL.) AACE Clin Case Rep. 2023;9(6):201-204 PMID: 38045793 PMCID: PMC10690401 12/04/2023

  • (Wolf Pulsiano SL, Sarvaideo JL.) AACE Clinical Case Reports. 1 November 2023;9(6):201-204 SCOPUS ID: 2-s2.0-85175345188 11/01/2023

  • (Hayes H, Russell R, Haugen A, Nagavally S, Sarvaideo J.) J Endocr Soc. 2022 Oct 11;6(11):bvac133 PMID: 36267595 PMCID: PMC9562816 10/22/2022

  • (Sarvaideo J, Doll E, Tangpricha V.) Endocr Pract. 2022 Mar;28(3):353-354 PMID: 35074501 SCOPUS ID: 2-s2.0-85125482531 01/26/2022

  • (Doll E, Gunsolus I, Thorgerson A, Tangpricha V, Lamberton N, Sarvaideo JL.) Endocr Pract. 2022 Mar;28(3):237-242 PMID: 34781041 SCOPUS ID: 2-s2.0-85121347509 11/16/2021

Publications of from the

© 2025 91九色视频.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 91九色视频 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

91九色视频's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.